Zobrazeno 1 - 10
of 5 699
pro vyhledávání: '"A Seftel"'
Autor:
Esther Lim, Megha L. Mehrotra, Katherine Lamba, Amanda Kamali, Kristina W. Lai, Erika Meza, Stephanie Bertsch-Merbach, Irvin Szeto, Catherine Ley, Andrew B. Martin, Julie Parsonnet, Peter Robinson, David Gebhart, Noemi Fonseca, Cheng-ting Tsai, David Seftel, Allyx Nicolici, David Melton, Seema Jain
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background To describe the methodology for conducting the CalScope study, a remote, population-based survey launched by the California Department of Public Health (CDPH) to estimate SARS-CoV-2 seroprevalence and understand COVID-19 disease b
Externí odkaz:
https://doaj.org/article/d3bcae0c9b684cbf938e01027eb268af
Autor:
Gaganvir Parmar, Matthew D. Seftel, Kathy Ganz, John Blake, Jelena L. Holovati, David S. Allan
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2542-2551 (2024)
HLA-matched allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for many patients. Unrelated HLA-matched donors are the most frequently used donor for HCT. When more than one donor transplant option is available, transplant cent
Externí odkaz:
https://doaj.org/article/bdbbfe70cb714175b7d81199639e5cef
Autor:
Alexander Lind, Eva Freyhult, Felipe de Jesus Cortez, Anita Ramelius, Rasmus Bennet, Peter V. Robinson, David Seftel, David Gebhart, Devangkumar Tandel, Marlena Maziarz, Helena Elding Larsson, Markus Lundgren, Annelie Carlsson, Anna-Lena Nilsson, Malin Fex, Carina Törn, Daniel Agardh, Cheng-ting Tsai, Åke Lernmark, Martina Persson, Gun Forsander, Johnny Ludvigsson, Ulf Samuelsson, Claude Marcus
Publikováno v:
EBioMedicine, Vol 104, Iss , Pp 105144- (2024)
Summary: Background: Two or more autoantibodies against either insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A) or zinc transporter 8 (ZnT8A) denote stage 1 (normoglycemia) or stage 2 (dysglycemia) type 1 diabetes prior to s
Externí odkaz:
https://doaj.org/article/a4975652334e42b38b70cf638422fb61
Publikováno v:
In Minerals Engineering October 2024 217
Autor:
Bhowmick, Subhamoy, Michielsen, Bart, Kus, Monika, Mullens, Steven, Cool, Pegie, Mihaela Seftel, Elena
Publikováno v:
In Separation and Purification Technology 19 February 2025 354 Part 2
Autor:
Persson, Martina, Forsander, Gun, Ludvigsson, Johnny, Samuelsson, Ulf, Marcus, Claude, Lind, Alexander, Freyhult, Eva, de Jesus Cortez, Felipe, Ramelius, Anita, Bennet, Rasmus, Robinson, Peter V., Seftel, David, Gebhart, David, Tandel, Devangkumar, Maziarz, Marlena, Larsson, Helena Elding, Lundgren, Markus, Carlsson, Annelie, Nilsson, Anna-Lena, Fex, Malin, Törn, Carina, Agardh, Daniel, Tsai, Cheng-ting, Lernmark, Åke
Publikováno v:
In eBioMedicine June 2024 104
Autor:
Matthew D. Seftel, Ivan Pasic, Gaganvir Parmar, Oliver Bucher, David S. Allan, Sita Bhella, Kevin Anthony Hay, Oluwaseun Ikuomola, Grace Musto, Anca Prica, Erin Richardson, Tony H. Truong, Kristjan Paulson
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9953-9967 (2023)
Background: Hematopoietic cell transplantation (HCT) is an established therapy for hematologic malignancies and serious non-malignant blood disorders. Despite its curative potential, HCT is associated with substantial toxicity and health resource uti
Externí odkaz:
https://doaj.org/article/68837b5ed0774b23892c3c247e8b55e7
Publikováno v:
In Journal of Environmental Chemical Engineering April 2024 12(2)
Autor:
Parmar, Gaganvir1,2 (AUTHOR) john.blake@dal.ca, Seftel, Matthew D.1,3 (AUTHOR) jelena.holovati@ualberta.ca, Ganz, Kathy1 (AUTHOR), Blake, John1,4 (AUTHOR), Holovati, Jelena L.1,5 (AUTHOR), Allan, David S.1,6 (AUTHOR) daallan@toh.ca
Publikováno v:
Current Oncology. May2024, Vol. 31 Issue 5, p2542-2551. 10p.
Autor:
Devangkumar Tandel, Brigette Hinton, Felipe de Jesus Cortez, David Seftel, Peter Robinson, Cheng-ting Tsai
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionAchieving early diagnosis of pre-symptomatic type 1 diabetes is critical to reduce potentially life-threatening diabetic ketoacidosis (DKA) at symptom onset, link patients to FDA approved therapeutics that can delay disease progression an
Externí odkaz:
https://doaj.org/article/a453589fc8cc495184731e79b1cd3b41